You are here

  • Home
  • Archive
  • Volume 21, Issue 5
  • Protease inhibitor monotherapy was non-inferior and cost-effective as maintenance therapy compared to triple therapy in viral load suppressed patients with HIV-1 infection

Article metrics

Article menu
Download PDFPDF
Therapeutics/prevention
Cost-effectiveness study
Protease inhibitor monotherapy was non-inferior and cost-effective as maintenance therapy compared to triple therapy in viral load suppressed patients with HIV-1 infection

 

Online download statistics by month:

Online download statistics by month: August 2016 to March 2024

AbstractFullPdf
Aug 20166927
Sep 20162641012
Oct 2016289520
Nov 2016136135
Dec 201615125
Jan 20171712
Feb 20173301
Mar 20171931
Apr 20172511
May 20172934
Jun 2017600
Jul 20172621
Aug 20172121
Sep 20172700
Oct 20173122
Nov 20173500
Dec 20172600
Jan 20183510
Feb 20182711
Mar 20182121
Apr 20182420
May 20183510
Jun 20183300
Jul 20182710
Aug 20182700
Sep 20183101
Oct 20184101
Nov 20181500
Dec 20182000
Jan 20192320
Feb 20192601
Mar 20193000
Apr 20193211
May 20191511
Jun 20193011
Jul 20191910
Aug 20193100
Sep 20191400
Oct 20192000
Nov 20191600
Dec 20191900
Jan 20201601
Feb 20203012
Mar 20201200
Apr 20201310
May 20201800
Jun 20202800
Jul 20202522
Aug 20201000
Sep 20202800
Oct 20202000
Nov 20201820
Dec 2020800
Jan 2021800
Feb 20212100
Mar 20211800
Apr 20211600
May 2021003
Jun 2021110
Oct 20211100
Nov 20212500
Dec 20212930
Jan 20221623
Feb 20221400
Mar 20222800
Apr 20221200
May 20225200
Jun 20224500
Jul 20222200
Aug 20225610
Sep 20224000
Oct 20224000
Nov 20221800
Dec 20221100
Jan 20232000
Feb 20234500
Mar 2023800
Apr 2023711
May 20231800
Jun 2023320
Jul 20231111
Aug 2023800
Sep 20231601
Oct 20232500
Nov 20232400
Dec 20232010
Jan 20242920
Feb 20241201
Mar 20242200
Total265679105